Product Information
OCELLA 3 MG-0.03 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1538 per EA under NDC 00555913167. Its NADAC has been published 658 times since Nov 28, 2013.
FDA first approved this application on May 11, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555913167
Classification
Generic
Dosage Form
KIT
Effective Date
6/17/2026
Approval Type
Authorized Generic (NDA)
FDA Application
NDA021098FDA Approved
5/11/2001
TE Code
AB
On Market Since
6/11/2001
Price Statistics
The NADAC for OCELLA 3 MG-0.03 MG TABLET has been published 658 times since Nov 28, 2013, and over the history we have for it it has declined 91.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1538 per EA |
|---|---|
| All-time high | $1.7954 (Feb 12, 2014) |
| All-time low | $0.1517 (Apr 17, 2024) |
| 52-week high | $0.1731 |
| 52-week low | $0.1538 |
| Median price | $0.3642 |
| Average price | $0.6197 |
| Largest weekly change | +27.6% (Jun 19, 2024) |
| Weeks tracked | 658 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
-2.7%
6M
-6.2%
1Y
-4.6%
3Y
-17.6%
5Y
-50.6%
All
-91.1%
Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OCELLA 3 MG-0.03 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OCELLA 3 MG-0.03 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1538 per EA (NDC 00555913167), effective Jul 1, 2026.
How has the price of OCELLA 3 MG-0.03 MG TABLET changed over time?
Over the history we have for it, the NADAC for OCELLA 3 MG-0.03 MG TABLET has declined 91.1%. It has been tracked across 658 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for OCELLA 3 MG-0.03 MG TABLET?
Since Nov 28, 2013, the NADAC for OCELLA 3 MG-0.03 MG TABLET has ranged from a low of $0.1517 (Apr 17, 2024) to a high of $1.7954 (Feb 12, 2014), with a median of $0.3642 per EA.
Are there cheaper alternatives to OCELLA 3 MG-0.03 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DROSPIRENONE-EE 3-0.03 MG TAB, is $0.1492 per EA — about 3% below OCELLA 3 MG-0.03 MG TABLET.
Who manufactures OCELLA 3 MG-0.03 MG TABLET?
OCELLA 3 MG-0.03 MG TABLET (NDC 00555913167) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.